Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-76.43M
↓ 84% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-41.55M
Historical baseline
PeriodValueYoY Change
TTM$-76.43M-22.1%
2024$-62.60M-20.2%
2023$-52.07M-13.5%
2022$-45.86M-36.2%
2021$-33.68M-84.4%
2020$-18.27M-827.7%
2019$-1.97M-